tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Bouchey, 3 are a BUY (100%).
Analyst David Bouchey, currently employed at AEGIS, carries an average stock price target met ratio of 33.33% that have a potential upside of 76.42% achieved within 734 days.
David Bouchey’s has documented 6 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMTI, Rockwell Medical at 19-Jun-2019.
Analyst best performing recommendations are on RMTI (ROCKWELL MEDICAL).
The best stock recommendation documented was for RMTI (ROCKWELL MEDICAL) at 10/19/2018. The price target of $11 was fulfilled within 734 days with a profit of $35.64 (76.42%) receiving and performance score of 1.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$3
$1.89 (170.27%)
$7
7 months 9 days ago
(24-Mar-2025)
0/16 (0%)
$1.74 (138.10%)
Buy
$5
$3.89 (350.45%)
$5
7 months 12 days ago
(21-Mar-2025)
0/2 (0%)
$3.65 (270.37%)
Buy
$5
$3.89 (350.45%)
$121
11 months 19 days ago
(14-Nov-2024)
0/2 (0%)
$2.51 (100.80%)
Buy
$110
5 years 8 months 6 days ago
(27-Feb-2020)
0/2 (0%)
$80.74 (275.94%)
Buy
$121
$119.89 (10800.90%)
$11
6 years 4 months 14 days ago
(19-Jun-2019)
1/3 (33.33%)
$86.68 (252.56%)
734
What Year was the first public recommendation made by David Bouchey?
